share_log

James Foster Bought 2.3% More Shares In Charles River Laboratories International

James Foster Bought 2.3% More Shares In Charles River Laboratories International

詹姆斯·福斯特又購買了查爾斯河國際實驗室2.3%的股份
Simply Wall St ·  2023/11/17 05:10

Those following along with Charles River Laboratories International, Inc. (NYSE:CRL) will no doubt be intrigued by the recent purchase of shares by James Foster, Chairman of the company, who spent a stonking US$1.0m on stock at an average price of US$178. While that only increased their holding size by 2.3%, it is still a big swing by our standards.

查爾斯河實驗室國際有限公司(紐約證券交易所代碼:CRL)的關注者無疑會被該公司董事長詹姆斯·福斯特最近購買股票所吸引,他花了100萬美元的驚人價格購買了股票,平均價格爲178美元。儘管這僅使他們的持股規模增加了2.3%,但按照我們的標準,這仍然是一個很大的波動。

Check out our latest analysis for Charles River Laboratories International

查看我們對查爾斯河國際實驗室的最新分析

Charles River Laboratories International Insider Transactions Over The Last Year

查爾斯河實驗室過去一年的國際內幕交易

In the last twelve months, the biggest single sale by an insider was when the Chief Commercial Officer & Corporate Executive VP, William Barbo, sold US$1.3m worth of shares at a price of US$217 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (US$190). So it may not tell us anything about how insiders feel about the current share price.

在過去的十二個月中,內部人士最大的一次出售是首席商務官兼公司執行副總裁威廉·巴博(William Barbo)以每股217美元的價格出售了價值130萬美元的股票。雖然我們通常不喜歡看到內幕拋售,但更令人擔憂的是銷售是否以較低的價格進行。一線希望是,此次拋售高於最新價格(190美元)。因此,它可能無法告訴我們內部人士對當前股價的看法。

In the last twelve months insiders purchased 9.87k shares for US$1.9m. On the other hand they divested 7.77k shares, for US$1.7m. In total, Charles River Laboratories International insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

在過去的十二個月中,內部人士以190萬美元的價格購買了9.87萬股股票。另一方面,他們以170萬美元的價格剝離了7.77萬股股票。查爾斯河實驗室國際內部人士的總購買量超過了去年的銷售額。您可以在下表中看到過去一年的內幕交易(由公司和個人進行的)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

insider-trading-volume
NYSE:CRL Insider Trading Volume November 17th 2023
紐約證券交易所:CRL 內幕交易量 2023 年 11 月 17 日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

還有很多其他公司有內部人士購買股票。你可能不想錯過這份業內人士正在收購的成長型公司的免費名單。

Insider Ownership Of Charles River Laboratories International

查爾斯河國際實驗室的內部所有權

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Charles River Laboratories International insiders own 1.1% of the company, worth about US$105m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

許多投資者喜歡檢查公司有多少股份由內部人士擁有。通常,內部人所有權越高,內部人士被激勵長期建立公司的可能性就越大。很高興看到查爾斯河實驗室國際內部人士擁有該公司1.1%的股份,價值約1.05億美元。大多數股東會樂於看到這種內幕所有權,因爲這表明管理層的激勵措施與其他股東非常一致。

So What Do The Charles River Laboratories International Insider Transactions Indicate?

那麼,查爾斯河實驗室國際內幕交易表明了什麼?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Charles River Laboratories International. One for the watchlist, at least! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 1 warning sign for Charles River Laboratories International you should be aware of.

很高興看到最近的購買。我們也從內幕交易的長期前景中獲得信心。一旦將內部人所有權的高額考慮在內,內部人士似乎肯定對查爾斯河實驗室國際持樂觀態度。至少有一個用於監視列表!雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決定之前,我們也一定要考慮股票面臨的風險。一個很好的例子:我們發現了查爾斯河國際實驗室的1個警告標誌,你應該注意。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,來看看這份有趣的公司的免費清單吧。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論